The Chemopreventive Bioflavonoid Apigenin Modulates Signal Transduction Pathways in Keratinocyte and Colon Carcinoma Cell Lines

Journal of Nutrition

Volumn 133, Issue 11 SUPPL. 1, 2003, Pages

  Van Dross, Rukiyah ^a   Xue, Yue ^a   Knudson, Alexandra ^a   Pelling, Jill C ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Apigenin; Flavonoid; Mitogen activated protein kinase

Indexed keywords

APIGENIN; BIOFLAVONOID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 2; UNCLASSIFIED DRUG;

ANIMAL CELL; CANCER CELL CULTURE; CANCER PREVENTION; COLON CARCINOMA; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; FRUIT; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KERATINOCYTE; MOUSE; NONHUMAN; PROTEIN TARGETING; SIGNAL TRANSDUCTION; VEGETABLE;

ANIMALIA; CERVUS ELAPHUS;

EID: 0242610804     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.11.3800s     Document Type: Conference Paper

References (21)

1. Peterson, J. & Dwyer, J. (1998) Flavonoids: dietary occurrence and biochemical activity. Nutr. Res. 18: 1995-2018.
2. Cook, N. C. & Samman, S. (1996) Flavonoids-chemistry, metabolism, cardioprotective effects and dietary sources. J. Nutr. Biochem. 7: 66-76.
3. Birt, D. F., Walker, B., Tibbels, M. G. & Bresnick, E. (1986) Antimutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol. Carcinogenesis 7: 959-963.
4. Kuo, M.-L. & Yang, N.-C. (1995) Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes. Biochem. Biophys. Res. Commun. 212: 767-775.
5. Fotsis, T., Pepper, M. S., Aktas, E., Breit, S., Rasku, S., Adlercreutz, H., Wahala, K., Montesano, R. & Schweigerer, L. (1997) Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 57: 2916-2921.
6. Lepley, D. M., Li, B., Birt, D. F. & Pelling, J. C. (1996) The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis 17: 2367-2375.
7. Chaumontet, C., Droumaguet, C., Bex, V., Heberden, C., Gaillard-Sanchez, I. & Martel, P. (1997) Flavonoids (apigenin, tangeretin) counteract tumor promoter-induced inhibition of intercellular communication of rat liver epithelial cells. Cancer Lett. 114: 207-210.
8. Wei, H., Tye, L., Bresnick, E. & Birt, D. F. (1990) Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res. 50: 499-502.
9. Birt, D. F., Mitchell, D. L., Gold, B., Pour, P. & Pinch, H. C. (1997) Inhibition of UV-light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res. 17: 85-92.
10. Hagiwara, M., Inoue, S., Tanaka, T., Nunoki, K., Ito, M. & Hidaka, H. (1988) Differential effects of flavonoids as inhibiros of tyrosine protein kinases and serine/threonine protein kinases. Biochem. Pharmacol. 37: 2987-2992.
11. Frigo, D. E., Doung, B. N., Melnik, L. I., Schief, L. S., Collins-Burow, B. M., Pace, D. K., Mclachlan, J. A. & Burow, M. E. (2002) Flavonoid phytochemicals regulate activator protein 1 signal transduction pathways in endometrial and kidney stable cell lines. J. Nutr. 132: 1848-1853.
12. Llorens, F., Garcia, L., Itarte, E. & Gomez, N. (2002) Apigenin and LY294002 prolong EGF-stimulated ERK1/2 activation in PC12 cells but are unable to induce full differentiation. FEBS Lett. 510: 149-153.
13. Yin, F., Giuliano, A. E. & Van Herle, A. J. (1999) Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Anticancer Res. 19: 4297-4303.
14. Davies, S. P., Reddy, H., Caivano, M. & Cohen, P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351: 95-105.
15. Agullo, G., Gamet-Payrastre, L., Manenti, S., Viala, C., Remesy, C., Chap, H. & Payrastre, B. (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol. 53: 1649-1657.
16. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M. & Fukami, Y. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262: 5592-5595.
17. Kim, T. J., Zhang, Y.-H., Kim, Y., Lee, C.-K., Lee, M.-K., Hong, J.-T. & Uyn, Y.-P. (2002) Effects of apigenin on the serum- and platelet derived growth factor-BB-induced proliferation of rat aortic vascular smooth muscle cells. Planta Med. 68: 605-609.
18. Strickland J. E., Greenhalgh, D. A., Koceva-Chyla, A., Hennings, H., Restrepo, C., Balaschak, M. & Yuspa, S. H. (1988) Development of murine epidermal cell lines which contain an activated Ha-ras oncogene and form papillomas in skin grafts in athymic nude mouse hosts. Cancer Res. 48: 165-169.
19. Jallepalli, P. V., Lengauer, C., Vogelstein, B. & Bunz, F. (2003) The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J. Biol. Chem. 278: 20475-20479.
20. Bae, H. W., Geiser, A. G., Kim, D. H., Chung, M. T., Burmester, J. K., Sporn, M. B., Roberts, A. B. & Kim, S. J. (1995) Characterization of the promoter region of the human transforming growth factor-beta Type II receptor gene. J. Biol. Chem. 270: 29460-29468.
21. McVean, M., Xiao, H., Isobe, K.-I. & Pelting, J. C. (2000) Increase in wildtype -53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. Carcinogenesis 21: 633-639.